Thursday, September 29, 2016

Micronase


Pronunciation: GLYE-bure-ide
Generic Name: Glyburide
Brand Name: DiaBeta


Micronase is used for:

Treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines.


Micronase is a sulfonylurea antidiabetic medicine. It works by causing the pancreas to release insulin, which helps to lower blood sugar.


Do NOT use Micronase if:


  • you are allergic to any ingredient in Micronase

  • you have type 1 diabetes or certain severe problems associated with diabetes (eg, diabetic ketoacidosis, diabetic coma)

  • you have moderate to severe burns or very high blood acid levels (acidosis)

  • you are pregnant and are within 2 weeks of the expected delivery date

  • you are taking bosentan

Contact your doctor or health care provider right away if any of these apply to you.



Before using Micronase:


Some medical conditions may interact with Micronase. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have had a severe allergic reaction (eg, a severe rash, hives, itching, breathing difficulties, dizziness) to any other sulfonamide medicine, such as acetazolamide, celecoxib, certain diuretics (eg, hydrochlorothiazide), glipizide, probenecid, sulfamethoxazole, valdecoxib, or zonisamide

  • if you have a history of liver, kidney, thyroid, or heart problems

  • if you have stomach or bowel problems (eg, stomach or bowel blockage, stomach paralysis), drink alcohol, or have had poor nutrition

  • if you have a certain nerve problem (autonomic neuropathy), very poor health, a high fever, a severe infection, severe diarrhea, or high blood acid levels, or have had a severe injury

  • if you have a history of certain hormonal problems (eg, adrenal or pituitary problems, syndrome of inappropriate secretion of antidiuretic hormone [SIADH]), low blood sodium levels, anemia, or glucose-6-phosphate dehydrogenase (G6PD) deficiency

  • if you will be having surgery

Some MEDICINES MAY INTERACT with Micronase. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Bosentan because liver problems may occur and the effectiveness of both medicines may be decreased

  • Beta-blockers (eg, propranolol) because the risk of low blood sugar may be increased. They may also hide certain signs of low blood sugar and make it more difficult to notice

  • Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril), anticoagulants (eg, warfarin), azole antifungals (eg, ketoconazole, miconazole), chloramphenicol, clarithromycin, clofibrate, disopyramide, fenfluramine, fluoxetine, insulin, monoamine oxidase inhibitors (MAOIs) (eg, phenelzine), nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), phenylbutazone, probenecid, quinolone antibiotics (eg, ciprofloxacin), salicylates (eg, aspirin), or sulfonamides (eg, sulfamethoxazole) because the risk of low blood sugar may be increased

  • Calcium channel blockers (eg, diltiazem), corticosteroids (eg, prednisone), decongestants (eg, pseudoephedrine), diazoxide, diuretics (eg, furosemide, hydrochlorothiazide), estrogens, hormonal contraceptives (eg, birth control pills), hydantoins (eg, phenytoin), isoniazid, niacin, phenothiazines (eg, promethazine), rifamycins (eg, rifampin), sympathomimetics (eg, albuterol, epinephrine, terbutaline), or thyroid supplements (eg, levothyroxine) because they may decrease Micronase's effectiveness, resulting in high blood sugar

  • Gemfibrozil because blood sugar may be increased or decreased

  • Cyclosporine because the risk of its side effects may be increased by Micronase

This may not be a complete list of all interactions that may occur. Ask your health care provider if Micronase may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Micronase:


Use Micronase as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Micronase by mouth with food as directed by your doctor.

  • If you are taking 1 dose daily, take Micronase with breakfast or the first main meal of the day unless your doctor tells you otherwise.

  • High amounts of dietary fiber may decrease Micronase's effectiveness, resulting in high blood sugar. If you have questions about fiber in your diet while you are taking Micronase, talk with your doctor.

  • Micronase works best if it is taken at the same time each day.

  • Continue to take Micronase even if you feel well. Do not miss any doses.

  • If you miss a dose of Micronase, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Micronase.



Important safety information:


  • Micronase may cause drowsiness, dizziness, blurred vision, or lightheadedness. These effects may be worse if you take it with alcohol or certain medicines. Use Micronase with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink large amounts of alcohol while you use Micronase. Alcohol may increase the risk of Micronase's side effects. Also, alcohol may rarely interact with Micronase and cause a serious reaction with symptoms such as flushing, nausea, vomiting, dizziness, or stomach pain. Talk with your doctor or health care provider before you drink alcohol while you use Micronase.

  • Carry an ID card at all times that says you have diabetes. Check your blood sugar levels as directed by your doctor. If they are often higher or lower than they should be and you take Micronase exactly as prescribed, tell your doctor.

  • Proper diet, regular exercise, and regular blood sugar testing are important for best results with Micronase. Follow the diet and exercise program given to you by your health care provider.

  • It may be harder to control your blood sugar during times of stress such as fever, infection, injury, or surgery. Talk with your doctor about how to control your blood sugar if any of these occur. Do not change the dose of your medicine without checking with your doctor.

  • Micronase may cause low blood sugar levels. Low blood sugar may make you anxious, sweaty, weak, dizzy, drowsy, or faint. It may also make your heart beat faster; make your vision change; give you a headache, chills, or tremors; or make you more hungry. It is a good idea to carry a reliable source of glucose (eg, tablets or gel) to treat low blood sugar. If this is not available, you should eat or drink a quick source of sugar like table sugar, honey, candy, orange juice, or non-diet soda. This will raise your blood sugar level quickly. Tell your doctor right away if this happens. To prevent low blood sugar, eat meals at the same time each day and do not skip meals.

  • Risk of low blood sugar may be increased by severe or prolonged exercise, drinking alcohol, or skipping meals.

  • Micronase is a sulfonylurea. It may increase the risk of death from heart disease. Talk with your doctor about the benefits and risks of this or other therapies to treat your condition.

  • Micronase may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Micronase. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Do not change from this type of glyburide (nonmicronized) to the micronized type without checking with your doctor. Their effectiveness may not be the same.

  • Micronase should not be used by itself to treat type 1 diabetes. If you have questions about using Micronase to treat type 1 diabetes, talk with your doctor.

  • Tell your doctor or dentist that you take Micronase before you receive any medical or dental care, emergency care, or surgery.

  • Lab tests, including fasting blood glucose and hemoglobin A1c, may be performed while you use Micronase. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Micronase with caution in the ELDERLY; they may be more sensitive to its effects, especially low blood sugar levels.

  • Micronase should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Micronase while you are pregnant. If you take Micronase during pregnancy, do not take it within 2 weeks of the expected delivery date without first checking with your doctor. It is not known if Micronase is found in breast milk. Do not breast-feed while taking Micronase.

When used for long periods of time, Micronase may not work as well. If your blood sugar has been under control and then becomes hard to manage, contact your doctor. Do not change the dose of your medicine without checking with your doctor.



Possible side effects of Micronase:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Feeling of stomach fullness; heartburn; nausea.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing, joint or muscle pain, tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); blisters on the skin; confusion; fainting; fever, chills, or persistent sore throat; irregular heartbeat; low blood sugar symptoms (eg, anxiety, dizziness, drowsiness, fast heartbeat, headache, lightheadedness, tremors, unusual sweating, weakness); severe or persistent blurred vision or other vision problems; symptoms of liver problems (eg, dark urine, loss of appetite, pale stools, stomach pain, yellowing of the eyes or skin); unusual bruising or bleeding; unusual tiredness or weakness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Micronase side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; confusion; fainting; fast heartbeat; lethargy; lightheadedness; seizures; severe dizziness or drowsiness; tremor; unusual sweating.


Proper storage of Micronase:

Store Micronase at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Micronase out of the reach of children and away from pets.


General information:


  • If you have any questions about Micronase, please talk with your doctor, pharmacist, or other health care provider.

  • Micronase is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Micronase. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Micronase resources


  • Micronase Side Effects (in more detail)
  • Micronase Dosage
  • Micronase Use in Pregnancy & Breastfeeding
  • Drug Images
  • Micronase Drug Interactions
  • Micronase Support Group
  • 0 Reviews for Micronase - Add your own review/rating


  • Micronase Prescribing Information (FDA)

  • Micronase Advanced Consumer (Micromedex) - Includes Dosage Information

  • Micronase Concise Consumer Information (Cerner Multum)

  • DiaBeta Prescribing Information (FDA)

  • Glyburide Monograph (AHFS DI)

  • Glyburide Professional Patient Advice (Wolters Kluwer)



Compare Micronase with other medications


  • Diabetes, Type 2

RAN-Tamsulosin




RAN-Tamsulosin may be available in the countries listed below.


Ingredient matches for RAN-Tamsulosin



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of RAN-Tamsulosin in the following countries:


  • Canada

International Drug Name Search

Malotilate




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0059937-28-9

Chemical Formula

C12-H16-O4-S2

Molecular Weight

288

Therapeutic Category

Hepatoprotective agent

Chemical Name

Propanedioic acid, 1,3-dithiol-2-ylidene-, bis(1-methylethyl) ester

Foreign Names

  • Malotilatum (Latin)
  • Malotilat (German)
  • Malotilate (French)
  • Malotilato (Spanish)

Generic Names

  • Malotilate (OS: USAN, JAN)
  • NKK 105 (IS)

Brand Name

  • Kantec
    Daiichi Sankyo, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Flufenazina




Flufenazina may be available in the countries listed below.


Ingredient matches for Flufenazina



Fluphenazine

Flufenazina (DCIT) is known as Fluphenazine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, September 28, 2016

Risperidona Decrox




Risperidona Decrox may be available in the countries listed below.


Ingredient matches for Risperidona Decrox



Risperidone

Risperidone is reported as an ingredient of Risperidona Decrox in the following countries:


  • Spain

International Drug Name Search

Mirapex ER Extended-Release Tablets


Pronunciation: PRAM-i-PEX-ole
Generic Name: Pramipexole
Brand Name: Mirapex ER


Mirapex ER Extended-Release Tablets are used for:

Treating the signs and symptoms of early Parkinson disease. It may also be used for other conditions as determined by your doctor.


Mirapex ER Extended-Release Tablets are a dopamine agonist. Exactly how Mirapex ER Extended-Release Tablets works is unknown. It may increase the action of certain chemical receptors in the brain.


Do NOT use Mirapex ER Extended-Release Tablets if:


  • you are allergic to any ingredient in Mirapex ER Extended-Release Tablets

  • you have severe kidney problems or are on dialysis

  • you are taking another medicine that has pramipexole in it

Contact your doctor or health care provider right away if any of these apply to you.



Before using Mirapex ER Extended-Release Tablets:


Some medical conditions may interact with Mirapex ER Extended-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have kidney problems, low blood pressure, lightheadedness when you sit or stand up, or daytime sleepiness

  • if you drink alcohol or have a history of compulsive behavior (eg, eating, gambling, shopping)

  • if you have trouble controlling your muscles

Some MEDICINES MAY INTERACT with Mirapex ER Extended-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Cimetidine because it may increase the risk of Mirapex ER Extended-Release Tablets's side effects

  • Butyrophenones (eg, haloperidol), metoclopramide, phenothiazines (eg, chlorpromazine), or thioxanthenes (eg, thiothixene) because they may decrease Mirapex ER Extended-Release Tablets's effectiveness

  • Levodopa because the risk of its side effects may be increased by Mirapex ER Extended-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Mirapex ER Extended-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Mirapex ER Extended-Release Tablets:


Use Mirapex ER Extended-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Mirapex ER Extended-Release Tablets. Talk to your pharmacist if you have questions about this information.

  • Take Mirapex ER Extended-Release Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Swallow Mirapex ER Extended-Release Tablets whole. Do not break, crush, or chew before swallowing.

  • Your dose will be started low and gradually increased to achieve the best results. Do not change your dose sooner than recommended.

  • Do not suddenly stop taking Mirapex ER Extended-Release Tablets without checking with your doctor. Severe side effects, including fever, mental or mood changes, and stiff muscles, may occur.

  • If you miss a dose of Mirapex ER Extended-Release Tablets, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once. If you miss several doses, contact your doctor before you start to take Mirapex ER Extended-Release Tablets again.

Ask your health care provider any questions you may have about how to use Mirapex ER Extended-Release Tablets.



Important safety information:


  • Mirapex ER Extended-Release Tablets may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Mirapex ER Extended-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol while you are using Mirapex ER Extended-Release Tablets.

  • Check with your doctor before you use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Mirapex ER Extended-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Mirapex ER Extended-Release Tablets may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Some patients who take Mirapex ER Extended-Release Tablets have reported suddenly falling asleep while performing daily activities (eg, driving, eating, conversing). Many patients reported drowsiness before falling asleep; however, some patients did not experience drowsiness and felt that they were alert immediately before suddenly falling asleep. Use caution when driving, operating machinery, or performing other activities that could be dangerous. Inform your doctor if you experience unusual drowsiness or sleepiness while using Mirapex ER Extended-Release Tablets.

  • Some people have experienced new, unusual, or increased urges (eg, gambling, sexual urges) while using Mirapex ER Extended-Release Tablets. Tell your doctor right away if you notice such effects.

  • Patients with Parkinson disease may have an increased risk of developing a certain type of skin cancer (melanoma). It is not known if Mirapex ER Extended-Release Tablets also increases the risk of melanoma. You may need to have skin exams while you are using Mirapex ER Extended-Release Tablets. Discuss any questions or concerns with your doctor.

  • Lab tests, including blood pressure or skin checks, may be performed while you use Mirapex ER Extended-Release Tablets. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Mirapex ER Extended-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially hallucinations.

  • Mirapex ER Extended-Release Tablets should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Mirapex ER Extended-Release Tablets while you are pregnant. It is not known if Mirapex ER Extended-Release Tablets are found in breast milk. Do not breast-feed while taking Mirapex ER Extended-Release Tablets.


Possible side effects of Mirapex ER Extended-Release Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; cough; dizziness; drowsiness; dry mouth; muscle spasms; nausea; stomach pain or upset; tiredness; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal thinking; balance problems; change in behavior, mood, or emotions; chest pain; confusion; decreased sexual ability; difficulty walking; fainting; hallucinations; increased urination; memory loss; muscle pain, tenderness, or weakness; new or unusual skin growths; severe or persistent drowsiness or sleepiness; shortness of breath; sudden irresistible urge to sleep or suddenly falling asleep at unusual times; swelling of the arms or legs; trouble swallowing; unusual or intense urges (eg, gambling, sexual urges); unusual twitching or muscle movements; vision changes; vivid dreams or daydreams.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Mirapex ER side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; chest pain; confusion; decrease in blood pressure; difficulty moving; drowsiness; nausea; sedation; vomiting.


Proper storage of Mirapex ER Extended-Release Tablets:

Store Mirapex ER Extended-Release Tablets at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Mirapex ER Extended-Release Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Mirapex ER Extended-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Mirapex ER Extended-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Mirapex ER Extended-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Mirapex ER resources


  • Mirapex ER Side Effects (in more detail)
  • Mirapex ER Use in Pregnancy & Breastfeeding
  • Drug Images
  • Mirapex ER Drug Interactions
  • 0 Reviews for Mirapex ER - Add your own review/rating


Compare Mirapex ER with other medications


  • Parkinson's Disease

Adco-Cefoxitin




Adco-Cefoxitin may be available in the countries listed below.


Ingredient matches for Adco-Cefoxitin



Cefoxitin

Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of Adco-Cefoxitin in the following countries:


  • South Africa

International Drug Name Search